期刊
CANCER LETTERS
卷 385, 期 -, 页码 188-197出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2016.10.024
关键词
CDK5RAP3; GSK-3 beta; beta-catenin; Survival; Gastric cancer
类别
资金
- National Key Clinical Specialty Discipline Construction Program of China [[2012]649]
- Fund of Fujian Province science and technology innovation talents
- National Natural Science Foundation of China for Young Scholars [31301172]
- Youth Research Projects of the Fujian province health system [2013-1-27]
CDK5RAP3 was isolated as a binding protein of the Cdk5 activator p35. Although CDK5RAP3 has been implicated in cancer progression, its expression and function have not been investigated in gastric cancer. Our study demonstrated that the mRNA and protein levels of CDK5RAP3 were markedly decreased in gastric tumor tissues when compared with respective adjacent non-tumor tissues. CDK5RAP3 in gastric cancer cells significantly reduced cell proliferation, migration, invasion and tumor xenograft growth through inhibition of beta-catenin. Secondly, CDK5RAP3 was found to suppress the phosphorylation of GSK-3 beta (Ser9), leading to the phosphorylation (Ser37/Thr41) and subsequent degradation of beta-catenin. Lastly, the prognostic value of CDK5RAP3 for overall survival was found to be dependent on beta-catenin cytoplasm/nucleus localization in human gastric cancer samples. Collectively, our results demonstrated that CDK5RAP3 negatively regulates the beta-catenin signaling pathway by repressing GSK-3 beta phosphorylation and could be a potential therapeutic target for gastric cancer. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据